These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21855271)

  • 21. Fixation and metal release from the Tifit femoral stem prosthesis. 5-year follow-up of 64 cases.
    Kärrholm J; Frech W; Nivbrant B; Malchau H; Snorrason F; Herberts P
    Acta Orthop Scand; 1998 Aug; 69(4):369-78. PubMed ID: 9798444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of periprosthetic femur fractures associated with a unique cementless stem design.
    Watts CD; Abdel MP; Lewallen DG; Berry DJ; Hanssen AD
    Clin Orthop Relat Res; 2015 Jun; 473(6):2045-53. PubMed ID: 25502478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Straight tapered titanium stem with alumina bearing in cementless primary total hip arthroplasty: a minimum 5-year follow-up.
    Hwang BH; Lee WS; Park KK; Yang IH; Han CD
    J Arthroplasty; 2011 Dec; 26(8):1310-7. PubMed ID: 21316911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Femoral remodeling after porous-coated total hip arthroplasty with and without hydroxyapatite-tricalcium phosphate coating: a prospective randomized trial.
    Tanzer M; Kantor S; Rosenthall L; Bobyn JD
    J Arthroplasty; 2001 Aug; 16(5):552-8. PubMed ID: 11503113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary total hip arthroplasty with hydroxyapatite coated titanium femoral stems. Does design philosophy influence long term outcome?: Results of a prospective randomised controlled trial with follow-up of 10-15 years.
    Sandiford NA; Skinner JA; East DJ; Butler-Manuel A; Hinves BL; Shepperd JA
    Acta Orthop Belg; 2014 Sep; 80(3):372-9. PubMed ID: 26280611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimum 10 year survivorship analysis of a partially coated hydroxyapatite tapered femoral stem in elderly patients with an average age over 75.
    Ulivi M; Meroni V; Orlandini LC; Berjano P; Sansone VC
    J Arthroplasty; 2013 Sep; 28(8):1372-7. PubMed ID: 23523506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a highly porous titanium cup (Tritanium) and a conventional hydroxyapatite-coated porous titanium cup: A retrospective analysis of clinical and radiological outcomes in hip arthroplasty among Japanese patients.
    Yoshioka S; Nakano S; Kinoshita Y; Nakamura M; Goto T; Hamada D; Sairyo K
    J Orthop Sci; 2018 Nov; 23(6):967-972. PubMed ID: 30055877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total hip arthroplasty with an uncemented hydroxyapatite-coated tapered titanium stem: results at a minimum of 10 years' follow-up in 104 hips.
    Bodén H; Salemyr M; Sköldenberg O; Ahl T; Adolphson P
    J Orthop Sci; 2006 Mar; 11(2):175-9. PubMed ID: 16568390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excellent long-term survival of an uncemented press-fit stem and screw cup in young patients: follow-up of 75 hips for 15-18 years.
    Reigstad O; Siewers P; Røkkum M; Espehaug B
    Acta Orthop; 2008 Apr; 79(2):194-202. PubMed ID: 18484244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of proximal porous-coated and grit-blasted surfaces of hydroxyapatite-coated stems.
    Won YY; Dorr LD; Wan Z
    J Bone Joint Surg Am; 2004 Jan; 86(1):124-8. PubMed ID: 14711954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The S-ROM hydroxyapatite proximally-coated modular femoral stem in revision hip replacement: results of 397 hips at a minimum ten-year follow-up.
    Imbuldeniya AM; Walter WK; Zicat BA; Walter WL
    Bone Joint J; 2014 Jun; 96-B(6):730-6. PubMed ID: 24891571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxyapatite-ceramic-coated femoral stems in revision hip surgery.
    Trikha SP; Singh S; Raynham OW; Lewis JC; Mitchell PA; Edge AJ
    J Bone Joint Surg Br; 2005 Aug; 87(8):1055-60. PubMed ID: 16049238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of hydroxyapatite-coated and non-hydroxyapatite-coated noncemented total hip arthroplasty in same patients.
    Lee JM; Lee CW
    J Arthroplasty; 2007 Oct; 22(7):1019-23. PubMed ID: 17920475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-generation proximally coated titanium femoral component: minimum 7-year results.
    Lachiewicz PF; Soileau ES; Bryant P
    Clin Orthop Relat Res; 2007 Dec; 465():117-21. PubMed ID: 17621229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early failure of a nonmodular titanium femoral stem after primary hip arthroplasty.
    Azzam KA; Austin MS; Sharkey PF
    J Arthroplasty; 2010 Feb; 25(2):333.e1-5. PubMed ID: 19150211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Eight-year follow-up of uncemented hydroxyapatite coated hip prosthesis for hip osteoarthritis secondary to developmental hip dysplasia].
    Sarıkaya B; Ataoğlu B; Görmeli G; Öztürk BY; Turanlı S
    Eklem Hastalik Cerrahisi; 2013; 24(2):91-5. PubMed ID: 23692196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncemented custom computer-assisted design and manufacture of hydroxyapatite-coated femoral components: survival at 10 to 17 years.
    Muirhead-Allwood SK; Sandiford N; Skinner JA; Hua J; Kabir C; Walker PS
    J Bone Joint Surg Br; 2010 Aug; 92(8):1079-84. PubMed ID: 20675750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective randomized study comparing electrochemically deposited hydroxyapatite and plasma-sprayed hydroxyapatite on titanium stems.
    Bøe BG; Röhrl SM; Heier T; Snorrason F; Nordsletten L
    Acta Orthop; 2011 Feb; 82(1):13-9. PubMed ID: 21189109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revision hip arthroplasty with a short femoral component in fractured hydroxyapatite fully coated femoral stem.
    Sangüesa-Nebot MJ; Soriano FC; Gabarda RF; Mordt CV
    J Arthroplasty; 2010 Oct; 25(7):1168.e13-6. PubMed ID: 19729273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a hydroxyapatite-coated stem in patients with Dorr Type C femoral bone.
    Kelly SJ; Robbins CE; Bierbaum BE; Bono JV; Ward DM
    Clin Orthop Relat Res; 2007 Dec; 465():112-6. PubMed ID: 17704696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.